CLDXのニュース
Celldex Therapeutics (CLDX) Presents At AAAAI Conference 2023/03/02 18:16:28 Seeking Alpha
The following slide deck was published by Celldex Therapeutics, Inc.
Celldex: Q4 Earnings Snapshot 2023/02/28 23:35:05 WTOP
HAMPTON, N.J. (AP) — HAMPTON, N.J. (AP) — Celldex Therapeutics Inc. (CLDX) on Tuesday reported a loss of $26.5 million…
Celldex GAAP EPS of -$0.56 beats by $0.03, revenue of $1.61M beats by $1.35M 2023/02/28 22:19:58 Seeking Alpha
Celldex press release (CLDX): Q4 GAAP EPS of -$0.56 beats by $0.03.Revenue of $1.61M (+387.9% Y/Y) beats by $1.35M.Cash, cash equivalents and marketable securities as of December…
Celldex Reports Fourth Quarter and Year End 2022 Financial Results and Provides Corporate Update 2023/02/28 21:01:00 GlobeNewswire
- Phase 1b multi-dose CSU data presented at AAAAI on February 26 - - Phase 2 CSU enrollment completion expected by Q3 2023 -
CLDX stock gains on Phase 1 data for urticaria candidate (NASDAQ:CLDX) 2023/02/27 15:42:51 Seeking Alpha
Celldex Therapeutics (CLDX) added ~12%after the biotech announced early-stage results for its experimental urticaria therapy barzolvolimab. Read the full story here.
Celldex Therapeutics Inc. (CLDX) Looks Set To Grow At A Great Clip In 2022 2022/04/06 12:00:00 Marketing Sentinel
Celldex Therapeutics Inc. (NASDAQ:CLDX) has a beta value of 2.76 and has seen 1.18 million shares traded in the last trading session. The company, currently valued at $1.68B, closed the last trade at $36.04 per share which meant it lost -$0.66 on the day or -1.80% during that session. The CLDX stock price is -58.71% … Celldex Therapeutics Inc. (CLDX) Looks Set To Grow At A Great Clip In 2022 Read More »
Celldex Therapeutics, Inc. 2021 Q4 - Results - Earnings Call Presentation 2022/03/01 06:12:51 Seeking Alpha
Celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2021 Results - Earnings Call Transcript 2022/03/01 01:57:16 Seeking Alpha
Celldex GAAP EPS of -$0.43 misses by $0.02, revenue of $0.33M misses by $0.84M (NASDAQ:CLDX) 2022/02/28 21:02:32 Seeking Alpha
Celldex press release (NASDAQ:CLDX): Q4 GAAP EPS of -$0.43 misses by $0.02.Revenue of $0.33M (-91.3% Y/Y) misses by $0.84M.
Celldex Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update 2022/02/28 21:01:00 GlobeNewswire
HAMPTON, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported financial results for the fourth quarter and year ended December 31, 2021 and provided a corporate update.
Celldex Therapeutics, Inc. 2021 Q4 - Results - Earnings Call Presentation 2022/03/01 06:12:51 Seeking Alpha
Celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2021 Results - Earnings Call Transcript 2022/03/01 01:57:16 Seeking Alpha
Celldex GAAP EPS of -$0.43 misses by $0.02, revenue of $0.33M misses by $0.84M (NASDAQ:CLDX) 2022/02/28 21:02:32 Seeking Alpha
Celldex press release (NASDAQ:CLDX): Q4 GAAP EPS of -$0.43 misses by $0.02.Revenue of $0.33M (-91.3% Y/Y) misses by $0.84M.
Celldex Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update 2022/02/28 21:01:00 GlobeNewswire
HAMPTON, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported financial results for the fourth quarter and year ended December 31, 2021 and provided a corporate update.